High Dose (54 Gy) Pre-Operative Helical Tomotherapy for Retroperitoneal Liposarcoma: Results of a Phase II Multicenter Study.

[1]  R. van Hillegersberg,et al.  The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis. , 2021, International journal of radiation oncology, biology, physics.

[2]  X. Li,et al.  Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline. , 2021, Practical radiation oncology.

[3]  J. Blay,et al.  Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. , 2020, The Lancet. Oncology.

[4]  C. Robertson-More,et al.  Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison. , 2019, Current oncology.

[5]  S. Bonvalot,et al.  Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group , 2019, Cancer.

[6]  C. Raut,et al.  Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. , 2016, Practical radiation oncology.

[7]  D. Kirsch,et al.  Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. , 2016, The Lancet. Oncology.

[8]  Narasimhan P. Agaram,et al.  Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma , 2016, Annals of surgery.

[9]  R. Abrams,et al.  Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. , 2015, International journal of radiation oncology, biology, physics.

[10]  D. Tyler,et al.  Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas. , 2015, Annals of surgery.

[11]  Yen-Lin Chen,et al.  Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. , 2014, International journal of radiation oncology, biology, physics.

[12]  J. Blay,et al.  Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  B. Pockaj,et al.  Excellent local control with preoperative radiation therapy, surgical resection, and intra‐operative electron radiation therapy for retroperitoneal sarcoma , 2014, Journal of surgical oncology.

[14]  J. Blay,et al.  Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  P. Terrier,et al.  Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  V. Brouste,et al.  High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma , 2012, Radiation oncology.

[17]  R. Slopsema,et al.  Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. , 2012, International journal of radiation oncology, biology, physics.

[18]  A. Schwahofer,et al.  The Influence of Different IMRT Techniques on the Peripheral Dose , 2009, Strahlentherapie und Onkologie.

[19]  S. Zefkili,et al.  Évaluation nationale de la tomothérapie hélicoïdale : description des indications, des contraintes de dose et des seuils de repositionnement , 2007 .

[20]  M. Heslin,et al.  Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma , 2006, Cancer.

[21]  P. Pisters,et al.  Retroperitoneal sarcoma , 2006, Cancer.

[22]  G. Nielsen,et al.  Radiation therapy for control of soft-tissue sarcomas resected with positive margins. , 2005, International journal of radiation oncology, biology, physics.

[23]  E. Stoeckle,et al.  Étude théorique d'une radiothérapie postopératoire avec modulation d'intensité d'un sarcome rétropéritonéal , 2004 .

[24]  J. Donohue,et al.  Operative Management of Primary Retroperitoneal Sarcomas: A Reappraisal of an Institutional Experience , 2004, Annals of surgery.

[25]  John C Roeske,et al.  A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[27]  B. Bui,et al.  Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  C. Catton,et al.  Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma , 2002, Annals of Surgical Oncology.

[29]  F. van Coevorden,et al.  Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  P. Terrier,et al.  Prognostic factors in retroperitoneal sarcoma , 2001, Cancer.

[31]  J M Woodruff,et al.  Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. , 1998, Annals of surgery.

[32]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[33]  J. Coindre,et al.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma , 1986, Cancer.

[34]  G. Kantor,et al.  [Radiotherapy for retroperitoneal sarcomas]. , 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[35]  C. Catton,et al.  Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  B. Bui,et al.  Evaluating surgery quality in soft tissue sarcoma. , 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[37]  J. Blay,et al.  Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  C. Mussi,et al.  Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  C. Catton,et al.  Outcome and prognosis in retroperitoneal soft tissue sarcoma. , 1994, International journal of radiation oncology, biology, physics.